当前位置: 首页 > 期刊 > 《中国中药杂志》 > 2014年第2期
编号:13142192
“中药组分”相关研究的发展现状分析及探讨(4)
http://www.100md.com 2014年1月15日 《中国中药杂志》 2014年第2期
     [33]刘丹, 郁丹红, 贾晓斌, 等.中药组分与组分生物药剂学分类系统构建[J].中国中药杂志, 2012, 37(19):2997.

    [34]刘丹, 贾晓斌, 萧伟.银杏内酯组分结构优化实验研究探讨[J].中国中药杂志, 2013, 38(12):1856.

    [35]郁丹红, 贾晓斌.药效学筛选表征丹参二萜醌组分整体性质的代表性成分研究[J].中国中药杂志, 2013, 38(12):1851.

    Analysis and discussion about current development of relevant studies on

    "traditional Chinese medicine components"

    LIU Dan, JIA Xiao-bin

    (Key Laboratory of New Drug Delivery System of Chinese Meteria Medica under State Administration of

    Traditional Chinese Medicine, Jiangsu Provincial Academy of Chinese Medicine, Nanjing 210028, China)

    [Abstract]As traditional Chinese medicine components have become a hotspot in the field of traditional Chinese medicine study, they have followed a development trend of diversity and false identification. In studies on a new modern product, we shall encourage the diversified development mode, but avoid the false concept identification of traditional Chinese medicine components. In this paper, by analyzing the current development of traditional Chinese medicine components and problems, we discussed the standardization of traditional Chinese medicine components, with the aim of reducing and avoiding the situations to study non-traditional Chinese medicine components as traditional Chinese medicine components.

    [Key words]traditional Chinese medicine component; standardization

    doi:10.4268/cjcmm20140203

    [责任编辑马超一], 百拇医药(刘丹 贾晓斌)
上一页1 2 3 4